ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1642

Mast Cells May Explain Sex Differences in Osteoarthritis Pain

Bella Mehta1, Edward DiCarlo2, Fei Wang3, Miguel Otero4, Eun Kyung Song5, Peter Sculco2, Mark Figgie2, Susan Goodman2, William Robinson5 and Dana Orange6, 1Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 2Hospital for Special Surgery, New York, NY, 3Weil Cornell Medical College, New York, NY, 4Hospital for Special Surgery Research Institute, New York, NY, 5Stanford University School of Medicine, Palo Alto, CA, 6The Rockefeller University, New York, NY

Meeting: ACR Convergence 2022

Keywords: Biomarkers, Osteoarthritis, Outcome measures, pain, Total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Abstracts: Osteoarthritis – Clinical

Session Type: Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: Women are at increased risk for knee osteoarthritis(OA) and report more severe pain than men at the time of total knee arthroplasty. It has been suggested that women are more likely to postpone surgery or suffer from central sensitization, but the precise mechanisms underlying sex differences in knee OA pain are poorly understood. We sought to examine if these sex differences are partly explained by synovial histology features in OA.

Methods: We compared sex differences in synovial histology features from tissues retrieved at the time of arthroplasty in a cohort of n=157 patients with end stage knee OA and patient reported outcomes of pain. Knee pain was measured using the PROMIS pain intensity score and the KOOS pain score. We also compared sex differences in tryptase levels in serum and synovial fluid obtained perioperatively. Standard of care synovial hematoxylin and eosin stained slides were graded by an expert pathologist for 13 features detailed in Table 1(lymphocytic infiltrates, lining hyperplasia, neutrophils, plasma cells, binucleate plasma cells, Russell bodies, sublining giant cells, lining giant cells, fibrin, detritus, fibrosis, mast cell count, and mucoid degeneration). Shapiro-Wilk test was used to assess the normality of the data. Unpaired t-test and Mann-Whitney test were used to compare normally and non-normally distributed data respectively.

Results: Compared to men(n=61), women(n=96) reported worse pain, as measured by the PROMIS pain intensity score(mean 7.2 vs 6.2, p=0.001) and the KOOS pain score(mean 57 vs 49,p=0.002). These differences were not explained by increased time from symptom onset to surgery, which was not different in women compared to men in this cohort(Figure 1). Synovial mast cell count was significantly higher in women compared to men(mean 63 vs 46/10hpf,p=0.004), and this remained significant after Bonferroni correction for multiple comparisons. No other synovial histology features were significantly different between men and women. In agreement with the increased synovial mast cell count, serum and synovial fluid tryptase levels were significantly increased in women compared to men(p< 0.0001)(Figure 2).

Conclusion: Compared to men, women with OA report increased pain at the time of knee arthroplasty, harbor increased synovial mast cell counts and have increased serum and synovial fluid tryptase levels. While there are multiple mice studies discussing the importance of mast cells in OA progression and pain, studies specifically evaluating the relative contribution of mast cells to sex-dependent differences in OA and pain are lacking, leaving a large knowledge gap in our understanding of sexual dimorphism in the biology of OA and pain related to it[1,2]. Our data suggests that mast cells may contribute to sex-differences in OA pain. Future studies and analyses on the effect of sex on mast cells and osteoarthritis pain might shed mechanistic and therapeutic insights into this poorly understood problem.

1) Sousa-Valente et al, Role of TrkA signalling and mast cells in the initiation of osteoarthritis pain in the monoiodoacetate model, OAC2018
2) Wang Q et al, IgE-mediated mast cell activation promotes inflammation and cartilage destruction in osteoarthritis, Elife2019

Supporting image 1

Table 1: Synovial Histology features described in Osteoarthritis (OA) Samples.

Supporting image 2

Figure 1: Comparison of PROMIS Pain, KOOS pain, Symptom Duration and Synovial Mast cell counts between n=157 patients (61 men and 96 women) at the time of total knee arthroplasty.

Supporting image 3

Figure 2: Comparing Tryptase levels in Serum (n= 49 for men and 91 for women) and Synovial fluid (n= 61 for men and 87 for women) between men and women perioperatively.


Disclosures: B. Mehta, None; E. DiCarlo, None; F. Wang, None; M. Otero, Regeneron Pharmaceuticals, Inc; E. Song, None; P. Sculco, None; M. Figgie, Wishbone, Lima, Mekanika, HS2; S. Goodman, Novartis, UCB; W. Robinson, None; D. Orange, None.

To cite this abstract in AMA style:

Mehta B, DiCarlo E, Wang F, Otero M, Song E, Sculco P, Figgie M, Goodman S, Robinson W, Orange D. Mast Cells May Explain Sex Differences in Osteoarthritis Pain [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/mast-cells-may-explain-sex-differences-in-osteoarthritis-pain/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/mast-cells-may-explain-sex-differences-in-osteoarthritis-pain/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology